High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy

Shigeta Keisuke; Kosaka Takeo; Kitano Shigehisa; Yasumizu Yota; Miyazaki Yasumasa; Mizuno Ryuichi; Shinojima Toshiaki; Kikuchi Eiji; Miyajima Akira; Tanoguchi Hitoshi; Hasegawa Shintaro; Oya Mototsugu

首页> 外文期刊>Annals of surgical oncology >High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy

【24h】

High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy

机译：高绝对单核细胞计数预测多西他赛化疗治疗的去势抵抗性前列腺癌患者的临床结果差

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The association of peripheral monocyte count and prostate cancer progression is not well characterized.

机译：外周血单核细胞计数与前列腺癌进展之间的关联尚未很好地表征。

著录项

来源
《Annals of surgical oncology》 |2016年第12期|共8页
作者
Shigeta Keisuke; Kosaka Takeo; Kitano Shigehisa; Yasumizu Yota; Miyazaki Yasumasa; Mizuno Ryuichi; Shinojima Toshiaki; Kikuchi Eiji; Miyajima Akira; Tanoguchi Hitoshi; Hasegawa Shintaro; Oya Mototsugu;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科学;
关键词

相似文献

外文文献
中文文献
专利

1. High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy [J] . Shigeta Keisuke, Kosaka Takeo, Kitano Shigehisa, Annals of surgical oncology . 2016,第12期

机译：高绝对单核细胞计数预测多西他赛化疗治疗的去势抵抗性前列腺癌患者的临床结果差
2. Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer [J] . Veccia Antonello, Caffo Orazio, De Giorgi Ugo, Future oncology . 2016,第4期

机译：多西紫杉醇作为去势抵抗性前列腺癌的一线化疗治疗的八十岁老人的临床结果
3. Higher serum testosterone levels predict poor prognosis in castration-resistant prostate cancer patients treated with docetaxel [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：血清睾酮水平更高的血清睾酮水平预测用多西紫杉醇治疗的阉割前列腺癌患者预后差
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Predicting neutropenia in breast cancer patients undergoing chemotherapy using a 2-stage FOS-3NN model trained on first cycle blood counts. [D] . Shirdel, Elize. 2005

机译：使用经过第一个周期血细胞计数训练的2期FOS-3NN模型预测正在接受化疗的乳腺癌患者的中性粒细胞减少。
6. Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy [O] . Takatsugu Okegawa, Naoshi Itaya, Hidehiko Hara, 2016

机译：多西他赛化疗治疗去势抵抗型前列腺癌患者中循环肿瘤细胞中表皮生长因子受体状态作为敏感性的预测生物标志物
7. Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy [O] . Takatsugu Okegawa, Naoshi Itaya, Hidehiko Hara, 2016

机译：循环肿瘤细胞中的表皮生长因子受体状态作为多西紫杉醇化疗治疗去势抵抗性前列腺癌患者敏感性的预测生物标志物

High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅